DEF 14A

Company

Nautilus Biotechnology, Inc.

Filed

April 29, 2025

Period of Report

December 31, 2024

Accession Number

0001808805-25-000043

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →